Concepedia

Marie Ménard

MM

Statistics

Publications

13

Citations

1.3K

H-Index

12

Active since

2013

Affiliations

Revolution Medicines (United States)(Current)

Broad Institute

Harvard University

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Marie Ménard is an author at Revolution Medicines (United States) specializing in oncology, medicine, and apoptosis.

ORCID

Publications per year

2013–2025

13

Publications

13

Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

Jingjing Jiang, Lingyan Jiang, Benjamin J. Maldonato et al. · Cancer Discovery · 2024 · 281 citations · Full text

, , +17

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

Johanna Theruvath, Marie Ménard, Benjamin Smith et al. · Nature Medicine · 2022 · 255 citations · Full text

, , +13

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 175 citations · Full text

, , +17

Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: a requirement for VDAC2 or Bak for efficient Bax apoptotic function

Thanh Ngoc Nguyen, Iris K. L. Tan, Robert L. Ninnis et al. · Cell Death and Differentiation · 2014 · 131 citations · Full text

, , +10

Apoptotic pore formation is associated with in-plane insertion of Bak or Bax central helices into the mitochondrial outer membrane

Dana Westphal, Grant Dewson, Marie Ménard et al. · Proceedings of the National Academy of Sciences · 2014 · 122 citations · Full text

, , +17

1–5 of 13